Nearly 8,000 rare diseases have been identified by researchers and affect an estimated 30 million people in the EU. It is crucial to ensure these patients are included in the drug decision-making and put at the centre of clinical trials. Biokinetica engages in rare disease clinical trials and is dedicated to helping find effective treatments for those patients.
